|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Feb 05 | Option Exercise | 2.02 | 4,600 | 9,284 | 6,209 | Feb 07 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Feb 05 | Sale | 17.45 | 4,600 | 80,249 | 1,609 | Feb 07 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jan 05 | Option Exercise | 2.02 | 4,600 | 9,284 | 6,209 | Jan 08 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jan 05 | Sale | 19.16 | 4,600 | 88,116 | 1,609 | Jan 08 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Dec 05 | Option Exercise | 2.02 | 4,600 | 9,284 | 6,209 | Dec 07 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Dec 05 | Sale | 16.30 | 4,600 | 74,996 | 1,609 | Dec 07 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Nov 22 | Option Exercise | 2.02 | 13,800 | 27,852 | 15,409 | Nov 27 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Nov 22 | Sale | 15.00 | 13,800 | 207,000 | 1,609 | Nov 27 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jul 05 | Option Exercise | 2.02 | 2,250 | 4,555 | 3,859 | Jul 07 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jul 05 | Sale | 17.30 | 2,250 | 38,915 | 1,609 | Jul 07 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jun 05 | Option Exercise | 2.02 | 2,250 | 4,555 | 3,859 | Jun 07 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jun 05 | Sale | 16.26 | 2,250 | 36,576 | 1,609 | Jun 07 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | May 05 | Option Exercise | 2.02 | 2,250 | 4,555 | 3,859 | May 09 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | May 05 | Sale | 20.87 | 2,250 | 46,957 | 1,609 | May 09 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Apr 05 | Option Exercise | 2.02 | 2,250 | 4,555 | 3,859 | Apr 07 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Apr 05 | Sale | 18.20 | 2,250 | 40,942 | 1,609 | Apr 07 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Mar 06 | Option Exercise | 2.02 | 2,250 | 4,555 | 3,859 | Mar 08 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Mar 06 | Sale | 23.75 | 2,250 | 53,440 | 1,609 | Mar 08 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Feb 06 | Option Exercise | 2.02 | 2,250 | 4,555 | 3,859 | Feb 08 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Feb 06 | Sale | 24.27 | 2,250 | 54,612 | 1,609 | Feb 08 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jan 05 | Option Exercise | 2.02 | 2,250 | 4,555 | 3,859 | Jan 09 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jan 05 | Sale | 26.40 | 2,250 | 59,404 | 1,609 | Jan 09 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Dec 05 | Option Exercise | 2.02 | 2,250 | 4,555 | 3,859 | Dec 07 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Dec 05 | Sale | 17.38 | 2,250 | 39,114 | 1,609 | Dec 07 06:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Nov 07 | Option Exercise | 2.02 | 2,250 | 4,555 | 3,859 | Nov 09 05:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Nov 07 | Sale | 19.20 | 2,250 | 43,194 | 1,609 | Nov 09 05:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Oct 05 | Option Exercise | 2.02 | 2,250 | 4,555 | 3,859 | Oct 07 05:00 PM |
AVTE | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Oct 05 | Sale | 15.75 | 2,250 | 35,447 | 1,609 | Oct 07 05:00 PM |
AVTE | NIVEN RALPH | Chief Scientific Officer | Sep 06 | Option Exercise | 2.02 | 2,250 | 4,555 | 3,859 | Sep 07 05:30 PM |
AVTE | NIVEN RALPH | Chief Scientific Officer | Sep 06 | Sale | 19.00 | 2,250 | 42,750 | 1,609 | Sep 07 05:30 PM |
AVTE | NIVEN RALPH | Chief Scientific Officer | Aug 18 | Option Exercise | 2.02 | 2,250 | 4,555 | 3,859 | Aug 19 05:00 PM |
AVTE | NIVEN RALPH | Chief Scientific Officer | Aug 18 | Sale | 21.18 | 2,250 | 47,657 | 1,609 | Aug 19 05:00 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite